Morphic Therapeutic
IPO News: Morphic Holding, Inc. Prices 6.0mm Share IPO at $15, the midpoint of the $14-$16 Marketing Range
Morphic Therapeutic

Morphic Holding Inc

Exchange: NASDAQ


Initial Filing Date: 05/30/19

Launch Date: 06/14/19

Pricing Date 06/26/19

IPO Price: $15.00

Price Range: $14.00 - $16.00

Initial Shares Offered (mm): 5.0

Shares Offered (Pre-Shoe | mm): 6.0

Amount Offered (mm): $90.0

% Secondary: 0.0%

Shares Outstanding (mm): 29.6

Market Value at Pricing (mm): $444.0

Offering as % of Market Value: 20.3%

Bookrunners: JEFF | COWEN | BMO | WF

Major Holders: Directors; Springer Entities; Omega Fund

Industry: Healthcare

Description: Morphic is a biopharmaceutical company applying their proprietary insights to integrins to discover and develop a pipeline of potentially first-in-class oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. 

Note: Emerging Growth Company

Reference Link: S-1/A